Profound Medical Corp.
PROF
$4.78
$0.061.27%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 43.04% | -35.34% | -11.61% | 28.44% | -55.70% |
| Total Depreciation and Amortization | -4.93% | -7.85% | -6.56% | 215.85% | -71.43% |
| Total Amortization of Deferred Charges | -402.22% | 0.00% | -2.17% | -- | -- |
| Total Other Non-Cash Items | -177.53% | -23.64% | 24.48% | -27.82% | 17.44% |
| Change in Net Operating Assets | -90.91% | 397.18% | -2,507.14% | -85.11% | 469.70% |
| Cash from Operations | 11.33% | -0.20% | -24.56% | 30.44% | -68.95% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 21.35% | 1.63% | 2.87% | -242.86% | -6.28% |
| Issuance of Common Stock | -- | -100.00% | -100.00% | 573,350.00% | 100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 100.00% | -- | -- |
| Cash from Financing | 5,461.35% | 1.48% | -103.31% | 10,342.71% | -5.29% |
| Foreign Exchange rate Adjustments | -3,186.11% | 194.74% | 76.10% | -374.14% | 110.33% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 499.50% | 2.04% | -147.44% | 301.93% | -31.19% |